Covidien Aims To Double Sales In Emerging Markets By 2017
This article was originally published in The Gray Sheet
Executive Summary
Covidien plans to double its sales in emerging markets, primarily China and India, to $2 billion over the next five to six years, CEO Jose E. Almeida said during the firm’s Sept. 8 investor meeting in New York.
You may also be interested in...
News In Brief
Scathing TAVR critique from Belgium; arrest of top CDRH official; more device industry news.
Covidien Plans April U.S. Launch Of Solitaire For Ischemic Strokes
Clot removal device gains 510(k) clearance earlier than expected, will compete with Stryker’s Merci clot retrieval system.
Covidien Plans April U.S. Launch Of Solitaire For Ischemic Strokes
Clot removal device gains 510(k) clearance earlier than expected, will compete with Stryker’s Merci clot retrieval system.